Hypertension and Heart Failure with Preserved Ejection Fraction
- PMID: 34051966
- DOI: 10.1016/j.hfc.2021.02.002
Hypertension and Heart Failure with Preserved Ejection Fraction
Abstract
The prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing rapidly, and its prognosis is as poor as that of HF with reduced EF. Hypertension is an important risk factor involved in the pathophysiology of HFpEF. Although treatment of hypertension lowers the incidence of HF and is beneficial in patients with HFpEF, there is conflicting evidence on this topic. This article discusses the pathophysiological mechanisms linking hypertension with HFpEF and also the current evidence on the treatment of hypertension in patients with HFpEF.
Keywords: Antihypertensive agents; Blood pressure; Heart failure; Hypertension.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure The authors have nothing to declare. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science and ICT (NRF-2020R1C1C1013627) and was also supported by Basic Science Research Program through the NRF funded by the Ministry of Education (NRF-2017R1D1A1B03034053).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
